What is Inogen Inc (INGN) stock price today?

Inogen Inc (INGN) currently trades at $7.11 per share. The stock has a market capitalization of $197.44M and a P/E ratio of —x.

Is INGN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Inogen Inc has a Smart Value Score of 49/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is 1.49.

What is Inogen Inc's revenue and earnings?

Inogen Inc has trailing twelve-month (TTM) revenue of $348.67M with profit margins of -6.52%. Earnings per share (EPS) is $-0.86.

Is Inogen Inc financially healthy?

Inogen Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of 1.49 places it in the distress.

INGN

Inogen Inc

NASDAQ: INGN · HEALTHCARE · MEDICAL DEVICES

$7.11

+1.57% today

Updated 2026-04-30

Market cap

$197.44M

P/E ratio

—

P/S ratio

0.57x

EPS (TTM)

$-0.86

Dividend yield

—

52W range

$5 – $9

Volume

0.3M

Market cap

$197.44M

P/E ratio

—

P/S ratio

0.57x

EPS (TTM)

$-0.86

Dividend yield

—

52W range

$5 – $9

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

5.3

Growth

C+

7.5

Quality

B+

2.0

Profitability

4.0

Valuation

4/9

Piotroski F-Score

Moderate

1.5

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$12.67

+78.20%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.09x — low leverage

Risks

- Altman Z 1.49 — distress zone

- Thin margins at -6.52%

- Negative free cash flow $-2.98M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$377.24M	$315.66M	$335.70M	$348.67M	$348.67M
Net income	$-83.77M	$-102.45M	$-35.89M	$-22.75M	$-7.13M
EPS	—	—	—	—	$-0.86
Free cash flow	$-58.75M	$-29.75M	$-11.18M	$-21.60M	$-2.98M
Profit margin	-22.21%	-32.46%	-10.69%	-6.52%	-6.52%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
INGN	$197.44M	49	5.3	2.0	4.0	7.5	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Inogen Inc trades at $7.11. Our Smart Value Score of 49/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.49, it sits in the distress. TTM revenue stands at $348.67M. with profit margins at -6.52%.

Frequently asked questions

What is Inogen Inc's stock price?

Inogen Inc (INGN) trades at $7.11.

Is Inogen Inc overvalued?

Smart Value Score 49/100 (Grade C, Sell).

What is the price target of Inogen Inc (INGN)?

The analyst target price is $12.67, representing +78.2% upside from the current price of $7.11.

What is Inogen Inc's revenue?

TTM revenue is $348.67M.

Piotroski F-Score?

4/9 — moderate financial health.

Altman Z-Score?

1.49 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.inogen.com

Quick metrics

P/S ratio0.57x

ROE-12.40%

Beta1.71

50D MA$6.33

200D MA$7.02

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

INGN vs LLY →INGN vs JNJ →INGN vs ABBV →Stock screener →